Avastin might be out of breast cancer

Posted by tln at 4 July, at 19 : 39 PM Print

Since aggressive diseases have been discovered, such as the several types of cancer, aids or Parkinson’s, new medication are constantly being developed as a way of trying to provide a new option for those who suffer from the symptoms. However, because these illnesses are aggressive from the beginning, the treatment is almost as bad as being sick.

Change Of Recommendations

One of the most dreadful perspectives of someone who is diagnosed with cancer is going through chemotherapy. Even after that stage, the patients still have to keep on taking drugs to maintain the progression of the case. For patients who are diagnosed with metastatic breast cancer, until last year it was possible to be treated with the drug known as Avastin.

However, the outside advisers for the Food and Drug Administration board have officially voted against keeping the product on the market for that specific type of cancer. It can still be commercialized, as it is also used for treatment in other cases. Colorectal and lung cancers are possibilities of diagnosis that might require the prescription of Avastin.

Results From Use

The reason for wanting the prohibition of the use of Avastin on cases of breast cancer is that the results on a long-term perspective were not that brightening. Also, one of the side effects which were frequently noticed is the possibility of deadly bleeding. So, in order to avoid future complications, the advisers had a 6-0 score against the medicine.

Member of the panel who voted, Ralph Freedman said “There are just so many questions here and the agency has to look at protecting a larger number of patients.” As these products are also very expensive for those who need it, the drop on the sales will affect the economic status of the producers. Another panel member, Natalie Compagni-Portis said “We all wanted Avastin to succeed, but the reality is that in these studies that we’re talking about, it did not.”

Health